Developer docs
API playgroundTry for free, no card

Search company profiles

Parallel Health

Full company profile

uuid00003u9

Namestring
Parallel Health
Legal namestring
Parallel Health, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Parallel Health, Inc. is a precision skin health company founded in 2021 and headquartered in San Francisco that has built an integrated platform combining whole genome skin microbiome sequencing, AI-driven analytics, personalized bacteriophage therapy, and tele-dermatology under the Microbiome Dermatology brand. Its flagship offering, the MD-03 Protocol, is a recurring subscription product that pairs an at-home Skin Discovery Test using quantitative WGS with a 1:1 clinical consultation and a custom Active Phage Serum formulated to the consumer's Skin Microbiome Type, priced at approximately $195 per month with a three-month minimum. The company also sells complementary skincare (Blue Biotic peptide cream, Holy Calming Cleanser, Skin Barrier Biotic Cream), a la carte microbiome tests ($495), custom compounded prescriptions, and condition-specific protocol extensions covering acne, eczema, rosacea, hidradenitis suppurativa, scalp, and body odor. Backed by a proprietary biorepository of more than 10,000 characterized microbial strains and eight pending patents, Parallel positions its approach as functional, root-cause dermatology rather than symptomatic treatment.

The company monetizes through four primary streams: MD-03 subscription recurring revenue, individual skincare product sales, one-time test kit purchases, and a clinical research services offering that licenses quantitative microbiome analysis, strain discovery, and formulation support to CPG and therapeutic companies. Distribution is multi-channel: a Shopify-powered DTC e-commerce site with global shipping, US telehealth prescription fulfillment in four states (CA, NY, FL, TX), employer corporate wellness partnerships, and clinical research sales. As of 2026 Parallel has secured in-network status with three major US insurance carriers (Aetna, Cigna, UnitedHealthcare) in California, making it the only microbiome dermatology platform with multi-carrier insurance coverage in the country. The company operates with a lean team of 1-10 employees, has raised approximately $1.95 million in disclosed funding across 2021-2022, and is led by co-founders Natalise Kalea Robinson (CEO, Stanford GSB MBA) and Dr. Nathan Brown (CSO), with Dr. Seaver Soon serving as Medical Director.

Short descriptiontext

Parallel Health is a San Francisco precision skin health company that combines quantitative whole-genome skin microbiome sequencing, AI analytics, personalized bacteriophage therapy, and tele-dermatology to deliver its MD-03 Protocol and condition-specific skincare to individual consumers, with growing clinical research services for CPG and therapeutic clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbiome dermatology, skin microbiome testing, phage therapy skincare, precision dermatology, telehealth dermatology
Industry1 code
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
NAICS code2 codes
  • Cosmetics, Beauty Supplies, and Perfume Retailers456120
  • Medical and Diagnostic Laboratories6215
SIC code3 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Services-Medical Laboratories8071
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Microbiome Dermatology / Precision Skincare
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1MD-03 Protocol Subscription
TypeSubscription Recurring
Description

Recurring monthly subscription model for the MD-03 Protocol combining Skin Discovery Test, 1:1 clinical consultation, and Custom Active Phage Serum at $195/month. Initial Skin Discovery Test is free after month 1 (valued at $495). Requires minimum three-month commitment for subscription products.

parallelhealth.io
2Skincare Product Sales
TypeSubscription Recurring
Description

Direct-to-consumer e-commerce sales of skincare products including Blue Biotic Multi-Effect Peptide Cream ($295), Holy Calming Cleanser ($55), Skin Barrier Biotic Cream ($135), and Custom Compounded Prescriptions ($95). Products sold individually or through subscription.

parallelhealth.io
3Clinical Research Services
TypeProfessional Services
Description

Partnership services for CPG and therapeutic companies including custom discovery programs, strain licensing, formulation support, clinical validation, and regulatory support for microbiome analysis.

parallelhealth.io
4Microbiome Test Kits
TypeOne Time License
Description

A la carte sales of skin microbiome test kits including Facial Skin Discovery Test ($495), Body Spot Test, Scalp Health Test, and Odor Discovery Test for individual purchase outside of subscription.

parallelhealth.io
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details7 tiers
1MD-03 Protocol subscription with Skin Discovery Test, clinical consultation, and Active Phage Serum
ModelSubscriptionBilling cadenceMonthly
Notes

$195/month. Includes Skin Discovery Test free after month 1 ($495 value) and 1:1 clinical consultation with MD at no additional cost. Minimum 3-month commitment required.

parallelhealth.io
2Blue Biotic Multi-Effect Peptide Cream premium anti-aging product
ModelOne time/ perpetual licenseBilling cadenceMonthly
Notes

$295 per unit. Currently out of stock.

parallelhealth.io
3Holy Calming Cleanser microbiome-friendly cleanser
ModelUnit PricingBilling cadenceMonthly
Notes

$55 per unit.

parallelhealth.io
4Skin Barrier Biotic Cream with probiotics, prebiotics, and ceramides
ModelUnit PricingBilling cadenceMonthly
Notes

$135 per unit.

parallelhealth.io
5Custom Compounded Prescription personalized formulation
ModelUnit PricingBilling cadenceMonthly
Notes

$95 per prescription.

parallelhealth.io
6Protocol programs for various skin conditions
ModelSubscriptionBilling cadenceMonthly
Notes

Programs for acne, body odor, discoloration, eczema, hidradenitis suppurativa, and rosacea priced between $195 and $260.

parallelhealth.io
7Facial Skin Discovery Test microbiome analysis
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$495 per test. Provides Skin Microbiome Type, skin age, diversity, and health factors.

parallelhealth.io
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 6 records shown
1MD-03 Protocol
Description

Flagship 3-step protocol combining whole genome sequencing, phage technology, and 1:1 provider care for personalized skin health treatment.

parallelhealth.io
+5 more records
Core offering1 text field

Parallel Health sells the MD-03 Protocol™, a precision skin health system that combines at-home quantitative whole genome sequencing skin microbiome testing, 1:1 telehealth consultations with board-certified dermatologists, and custom-compiled active phage serums personalized to each customer's Skin Microbiome Type™. The company also sells individual precision skincare products (Blue Biotic™ Peptide Cream, Holy Calming Cleanser, Skin Barrier Biotic™ Cream), stand-alone microbiome test kits, custom compounded prescriptions, and condition-specific protocols for acne, eczema, rosacea, body odor, hidradenitis suppurativa, and scalp issues, available via subscription or à la carte purchase.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 99.9% reduction in inflammation and blemishes in dermatologist-led study
+2 more records
Product overview1 text field

Parallel Health is a vertically integrated precision skin health platform offering a portfolio of products centered on its Microbiome Dermatology™ approach. The core offering is the MD-03 Protocol™, a 3-step system combining at-home skin microbiome testing via whole genome sequencing, 1:1 telehealth consultations with dermatologists, and custom compounded phage serums. Supporting products include the Blue Biotic™ Multi-Effect Peptide Cream (anti-aging), Holy Calming Cleanser, Skin Barrier Biotic™ Cream, and various condition-specific protocols (Acne, Eczema, Rosacea, Hidradenitis Suppurativa, Scalp, Body Odor). The company also offers clinical research services using its proprietary quantitative whole genome sequencing platform. Products are available direct-to-consumer via subscription and a la carte, with insurance coverage in California through Aetna, Cigna, and UnitedHealthcare.

Product and service18 records
1MD-03 Protocol™
CategoryCore protocol
Description

Flagship 3-step precision skin health protocol combining at-home quantitative whole genome sequencing skin microbiome testing, 1:1 dermatologist telehealth consultation, and custom active phage serum delivery. Addresses aging, acne, eczema, rosacea, melasma, body odor, scalp, and hidradenitis suppurativa. Sold as a monthly subscription at $195/month with a 3-month minimum commitment.

2Blue Biotic™ Multi-Effect Peptide Cream
CategorySkincare product
Description

Microbiome-based anti-aging peptide cream with 34 clinically proven ingredients. Claims 63% wrinkle reduction in 28 days and 100-150% increase in collagen production. Positioned as a non-invasive Botox alternative. Sold at $295 per unit.

3Daily Rewind Duo
CategorySkincare bundle
Description

Anti-aging skincare duo product combining two formulations for comprehensive skin renewal.

4Daily Reset Duo
CategorySkincare bundle
Description

Bundle containing Holy Calming Cleanser and Skin Barrier Silk Cream for daily cleansing and moisturizing.

5Custom Compounded Prescription
CategoryCustom compounded prescription
Description

Personalized prescription formulations prescribed by board-certified dermatologists based on individual medical needs and microbiome profile, targeting conditions like acne, rosacea, and melasma. Priced at $95 per prescription; limited to California, New York, Florida, and Texas.

6Skin Barrier Biotic™ Cream
CategorySkincare product
Description

Moisturizer combining probiotics, prebiotics, and postbiotics with barrier-repairing ceramides and soothing allantoin for microbiome support. Priced at $135 per unit.

7Holy Calming Cleanser
CategorySkincare product
Description

Microbiome-friendly cleanser containing proprietary prebiotic extracts to support calm skin and better aging, gently hydrating and nourishing sensitive skin. Priced at $55 per unit.

8Facial Skin Discovery Test
CategoryMicrobiome test kit
Description

At-home skin microbiome test using whole genome sequencing to provide comprehensive report of microbial composition, skin age, diversity, and health factors. Retail value $495.

9Body Spot Test
CategoryMicrobiome test kit
Description

Skin microbiome test for problem areas on the body to discover microbial composition and learn how to improve balance.

10Odor Discovery Test
CategoryMicrobiome test kit
Description

Skin microbiome test to discover odor profile and learn what makes up unique body scent.

11Scalp Health Test
CategoryMicrobiome test kit
Description

Comprehensive scalp microbiome analysis through simple swab, providing insights into individual scalp health and microbial profile with dermatologist consultation.

12Custom Active Phage Serum
CategoryCustom topical serum
Description

Personalized phage serum with nourishing ingredients and precision phage cocktail designed for individual skin microbiome, delivered as part of MD-03 Protocol.

13MD-03 Scalp Protocol™
CategoryCondition-specific protocol
Description

Personalized teledermatology solution addressing scalp health concerns like hair loss and irritation using microbiome-focused approach. Condition-specific variant of the MD-03 Protocol.

14MD-03 Body Odor Protocol™
CategoryCondition-specific protocol
Description

Personalized microbiome dermatology approach to manage body odor through tailored treatments including skin microbiome test and custom phage serum. Condition-specific variant of the MD-03 Protocol.

15MD-03 Hidradenitis Suppurativa Protocol™
CategoryCondition-specific protocol
Description

Personalized treatment to identify bacterial causes and manage HS flare-ups through targeted therapies including microbiome test and customized prescriptions. Condition-specific variant of the MD-03 Protocol.

16MD-03 Eczema Protocol™
CategoryCondition-specific protocol
Description

Personalized teledermatology approach to managing eczema featuring skin microbiome test, custom phage serum, and ongoing medical guidance. Condition-specific variant of the MD-03 Protocol.

17MD-03 Rosacea Protocol™
CategoryCondition-specific protocol
Description

Personalized treatment plan targeting root causes of rosacea including redness and inflammation through customized phage therapy and prescriptions. Condition-specific variant of the MD-03 Protocol.

18Quantitative Whole Genome Sequencing Clinical Research Platform
CategoryClinical research services / B2B platform
Description

Proprietary clinical research technology providing absolute microbial quantification, comprehensive taxonomic coverage (bacteria, fungi, viruses, bacteriophages), and functional genomic insights including virulence factors and metabolic pathways. Offered as a B2B service for CPG and therapeutic companies, clinical researchers, and academic institutions.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-07
Description

Parallel Health achieved in-network status with UnitedHealthcare in California, expanding access to its Microbiome Dermatology platform. Allows Californians with UnitedHealthcare plans to access personalized skin health care through telehealth at in-network rates, covering over 49 million members nationally.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-19
Description

Parallel Health achieved in-network status with Cigna Healthcare in California, marking its second major national insurance carrier partnership. Establishes Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the United States.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

In-network status with Aetna in California, following an earlier partnership. First major national insurance carrier partnership establishing Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the US.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Accelerator program participant providing access to Illumina's genomics technology and resources for advancing microbiome sequencing capabilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Accelerator program participant at Stanford University providing startup support, mentorship, and resources.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Competed as TOP 6 (TOP 0.2%) finalist at TechCrunch Disrupt startup competition, gaining visibility and recognition in the startup ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership opportunities for CPG and therapeutic companies including custom discovery programs, strain licensing, formulation support, clinical validation, and regulatory support using Parallel Health's quantitative microbiome analysis platform.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Telehealth dermatology provider offering personalized prescription skincare for acne and anti-aging via subscription. Closest direct competitor in the personalized tele-derm + custom Rx category Parallel operates in.

TypeDirect peer
Description

Online dermatology practice delivering customized compounded prescription skincare. Directly comparable business model of telehealth consultation + custom compounded Rx delivered to consumer.

TypeBroad incumbent
Description

Large public telehealth platform that has expanded into dermatology and personalized skincare. Competes in tele-derm and custom Rx but as part of a much broader men's/women's health portfolio.

TypeDirect peer
Description

Data-driven personalized skincare using at-home testing to formulate serums. Highly comparable on the test-driven, custom-formulation, DTC-subscription model.

TypeDirect peer
Description

AI-personalized skincare brand using a personalization quiz and custom-formulated products. Comparable on the AI-driven, custom formulation, DTC model aimed at anti-aging consumers.

TypeDirect peer
Description

Microbiome-focused skincare brand built around live bacterial topical products. Direct peer in the consumer microbiome skincare category, sharing Parallel's positioning.

7Sundial Skin
TypeEmerging player
Description

Early-stage microbiome skincare brand targeting acne and chronic skin conditions with proprietary topical strains. Emerging player in adjacent microbiome skincare niche.

8Codex Beauty
TypeDirect peer
Description

Microbiome-focused clinical skincare brand with a BiaSkin platform combining prebiotics, probiotics and postbiotics. Comparable on microbiome + clinical claims positioning.

9DermaDNA
TypeEmerging player
Description

Genetic and microbiome-based personalized skincare offering tailored regimens from DNA and skin analysis. Emerging player in the personalized skincare diagnostics category.

TypeEmerging player
Description

Genetic-based skincare analysis and product recommendation platform. Adjacent personalized skincare diagnostics peer leveraging biological data for custom regimen recommendations.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration11 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Parallel Health

Microbiome Dermatology / Precision Skincareparallelhealth.io

Parallel Health is a San Francisco precision skin health company that combines quantitative whole-genome skin microbiome sequencing, AI analytics, personalized bacteriophage therapy, and tele-dermatology to deliver its MD-03 Protocol and condition-specific skincare to individual consumers, with growing clinical research services for CPG and therapeutic clients.

What Parallel Health does

Parallel Health, Inc. is a precision skin health company founded in 2021 and headquartered in San Francisco that has built an integrated platform combining whole genome skin microbiome sequencing, AI-driven analytics, personalized bacteriophage therapy, and tele-dermatology under the Microbiome Dermatology brand. Its flagship offering, the MD-03 Protocol, is a recurring subscription product that pairs an at-home Skin Discovery Test using quantitative WGS with a 1:1 clinical consultation and a custom Active Phage Serum formulated to the consumer's Skin Microbiome Type, priced at approximately $195 per month with a three-month minimum. The company also sells complementary skincare (Blue Biotic peptide cream, Holy Calming Cleanser, Skin Barrier Biotic Cream), a la carte microbiome tests ($495), custom compounded prescriptions, and condition-specific protocol extensions covering acne, eczema, rosacea, hidradenitis suppurativa, scalp, and body odor. Backed by a proprietary biorepository of more than 10,000 characterized microbial strains and eight pending patents, Parallel positions its approach as functional, root-cause dermatology rather than symptomatic treatment.

The company monetizes through four primary streams: MD-03 subscription recurring revenue, individual skincare product sales, one-time test kit purchases, and a clinical research services offering that licenses quantitative microbiome analysis, strain discovery, and formulation support to CPG and therapeutic companies. Distribution is multi-channel: a Shopify-powered DTC e-commerce site with global shipping, US telehealth prescription fulfillment in four states (CA, NY, FL, TX), employer corporate wellness partnerships, and clinical research sales. As of 2026 Parallel has secured in-network status with three major US insurance carriers (Aetna, Cigna, UnitedHealthcare) in California, making it the only microbiome dermatology platform with multi-carrier insurance coverage in the country. The company operates with a lean team of 1-10 employees, has raised approximately $1.95 million in disclosed funding across 2021-2022, and is led by co-founders Natalise Kalea Robinson (CEO, Stanford GSB MBA) and Dr. Nathan Brown (CSO), with Dr. Seaver Soon serving as Medical Director.

Parallel Health firmographics

Firmographics
Name
Parallel Health
Legal name
Parallel Health, Inc.
Website
https://parallelhealth.io
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Parallel Health is a San Francisco precision skin health company that combines quantitative whole-genome skin microbiome sequencing, AI analytics, personalized bacteriophage therapy, and tele-dermatology to deliver its MD-03 Protocol and condition-specific skincare to individual consumers, with growing clinical research services for CPG and therapeutic clients.
Ownership category
akta.pro rank

Parallel Health industry classification

Industry
Product category
Microbiome Dermatology / Precision Skincare
NAICS
Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Medical and Diagnostic Laboratories (6215)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare

Keywords

  • Microbiome dermatology
  • Skin microbiome testing
  • Phage therapy skincare
  • Precision dermatology
  • Telehealth dermatology

Where Parallel Health is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Parallel Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. MD-03 Protocol Subscription: Recurring monthly subscription model for the MD-03 Protocol combining Skin Discovery Test, 1:1 clinical consultation, and Custom Active Phage Serum at $195/month. Initial Skin Discovery Test is free after month 1 (valued at $495). Requires minimum three-month commitment for subscription products.
  2. Skincare Product Sales: Direct-to-consumer e-commerce sales of skincare products including Blue Biotic Multi-Effect Peptide Cream ($295), Holy Calming Cleanser ($55), Skin Barrier Biotic Cream ($135), and Custom Compounded Prescriptions ($95). Products sold individually or through subscription.
  3. Clinical Research Services: Partnership services for CPG and therapeutic companies including custom discovery programs, strain licensing, formulation support, clinical validation, and regulatory support for microbiome analysis.
  4. Microbiome Test Kits: A la carte sales of skin microbiome test kits including Facial Skin Discovery Test ($495), Body Spot Test, Scalp Health Test, and Odor Discovery Test for individual purchase outside of subscription.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyMD-03 Protocol subscription with Skin Discovery Test, clinical consultation, and Active Phage Serum
One time/ perpetual licenseMonthlyBlue Biotic Multi-Effect Peptide Cream premium anti-aging product
Unit PricingMonthlyHoly Calming Cleanser microbiome-friendly cleanser
Unit PricingMonthlySkin Barrier Biotic Cream with probiotics, prebiotics, and ceramides
Unit PricingMonthlyCustom Compounded Prescription personalized formulation
SubscriptionMonthlyProtocol programs for various skin conditions
Unit PricingPay-as-you-goFacial Skin Discovery Test microbiome analysis

Go-to-market motion4 records

Distribution channels6 records

Marketing channels7 records

Parallel Health product offering

Product offering

Core offering

Parallel Health sells the MD-03 Protocol™, a precision skin health system that combines at-home quantitative whole genome sequencing skin microbiome testing, 1:1 telehealth consultations with board-certified dermatologists, and custom-compiled active phage serums personalized to each customer's Skin Microbiome Type™. The company also sells individual precision skincare products (Blue Biotic™ Peptide Cream, Holy Calming Cleanser, Skin Barrier Biotic™ Cream), stand-alone microbiome test kits, custom compounded prescriptions, and condition-specific protocols for acne, eczema, rosacea, body odor, hidradenitis suppurativa, and scalp issues, available via subscription or à la carte purchase.

Product overview

Parallel Health is a vertically integrated precision skin health platform offering a portfolio of products centered on its Microbiome Dermatology™ approach. The core offering is the MD-03 Protocol™, a 3-step system combining at-home skin microbiome testing via whole genome sequencing, 1:1 telehealth consultations with dermatologists, and custom compounded phage serums. Supporting products include the Blue Biotic™ Multi-Effect Peptide Cream (anti-aging), Holy Calming Cleanser, Skin Barrier Biotic™ Cream, and various condition-specific protocols (Acne, Eczema, Rosacea, Hidradenitis Suppurativa, Scalp, Body Odor). The company also offers clinical research services using its proprietary quantitative whole genome sequencing platform. Products are available direct-to-consumer via subscription and a la carte, with insurance coverage in California through Aetna, Cigna, and UnitedHealthcare.

Differentiator

Problem solved

Functional benefit

Brands

  • MD-03 Protocol: Flagship 3-step protocol combining whole genome sequencing, phage technology, and 1:1 provider care for personalized skin health treatment.
  • Blue Biotic
  • Skin Barrier Biotic
  • Holy Calming Cleanser
  • Daily Rewind Duo
  • Daily Reset Duo

Products and services

  • MD-03 Protocol™ Flagship 3-step precision skin health protocol combining at-home quantitative whole genome sequencing skin microbiome testing, 1:1 dermatologist telehealth consultation, and custom active phage serum delivery. Addresses aging, acne, eczema, rosacea, melasma, body odor, scalp, and hidradenitis suppurativa. Sold as a monthly subscription at $195/month with a 3-month minimum commitment.
  • Blue Biotic™ Multi-Effect Peptide Cream Microbiome-based anti-aging peptide cream with 34 clinically proven ingredients. Claims 63% wrinkle reduction in 28 days and 100-150% increase in collagen production. Positioned as a non-invasive Botox alternative. Sold at $295 per unit.
  • Daily Rewind Duo Anti-aging skincare duo product combining two formulations for comprehensive skin renewal.
  • Daily Reset Duo Bundle containing Holy Calming Cleanser and Skin Barrier Silk Cream for daily cleansing and moisturizing.
  • Custom Compounded Prescription Personalized prescription formulations prescribed by board-certified dermatologists based on individual medical needs and microbiome profile, targeting conditions like acne, rosacea, and melasma. Priced at $95 per prescription; limited to California, New York, Florida, and Texas.
  • Skin Barrier Biotic™ Cream Moisturizer combining probiotics, prebiotics, and postbiotics with barrier-repairing ceramides and soothing allantoin for microbiome support. Priced at $135 per unit.
  • Holy Calming Cleanser Microbiome-friendly cleanser containing proprietary prebiotic extracts to support calm skin and better aging, gently hydrating and nourishing sensitive skin. Priced at $55 per unit.
  • Facial Skin Discovery Test At-home skin microbiome test using whole genome sequencing to provide comprehensive report of microbial composition, skin age, diversity, and health factors. Retail value $495.
  • Body Spot Test Skin microbiome test for problem areas on the body to discover microbial composition and learn how to improve balance.
  • Odor Discovery Test Skin microbiome test to discover odor profile and learn what makes up unique body scent.
  • Scalp Health Test Comprehensive scalp microbiome analysis through simple swab, providing insights into individual scalp health and microbial profile with dermatologist consultation.
  • Custom Active Phage Serum Personalized phage serum with nourishing ingredients and precision phage cocktail designed for individual skin microbiome, delivered as part of MD-03 Protocol.
  • MD-03 Scalp Protocol™ Personalized teledermatology solution addressing scalp health concerns like hair loss and irritation using microbiome-focused approach. Condition-specific variant of the MD-03 Protocol.
  • MD-03 Body Odor Protocol™ Personalized microbiome dermatology approach to manage body odor through tailored treatments including skin microbiome test and custom phage serum. Condition-specific variant of the MD-03 Protocol.
  • MD-03 Hidradenitis Suppurativa Protocol™ Personalized treatment to identify bacterial causes and manage HS flare-ups through targeted therapies including microbiome test and customized prescriptions. Condition-specific variant of the MD-03 Protocol.
  • MD-03 Eczema Protocol™ Personalized teledermatology approach to managing eczema featuring skin microbiome test, custom phage serum, and ongoing medical guidance. Condition-specific variant of the MD-03 Protocol.
  • MD-03 Rosacea Protocol™ Personalized treatment plan targeting root causes of rosacea including redness and inflammation through customized phage therapy and prescriptions. Condition-specific variant of the MD-03 Protocol.
  • Quantitative Whole Genome Sequencing Clinical Research Platform Proprietary clinical research technology providing absolute microbial quantification, comprehensive taxonomic coverage (bacteria, fungi, viruses, bacteriophages), and functional genomic insights including virulence factors and metabolic pathways. Offered as a B2B service for CPG and therapeutic companies, clinical researchers, and academic institutions.

Quantifiable outcome

  • 99.9% reduction in inflammation and blemishes in dermatologist-led study
  • +2 more outcomes

Companies that use Parallel Health

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Parallel Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability4 records

Feature7 records

Parallel Health partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • UnitedHealthcarecoreChannel Partner/ Reseller/ Distributor · 7 April 2026Parallel Health achieved in-network status with UnitedHealthcare in California, expanding access to its Microbiome Dermatology platform. Allows Californians with UnitedHealthcare plans to access personalized skin health care through telehealth at in-network rates, covering over 49 million members nationally.
  • Cigna HealthcarecoreChannel Partner/ Reseller/ Distributor · 19 February 2026Parallel Health achieved in-network status with Cigna Healthcare in California, marking its second major national insurance carrier partnership. Establishes Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the United States.
  • AetnacoreChannel Partner/ Reseller/ DistributorIn-network status with Aetna in California, following an earlier partnership. First major national insurance carrier partnership establishing Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the US.
  • Illumina AcceleratorminorStrategic or Co-development PartnerAccelerator program participant providing access to Illumina's genomics technology and resources for advancing microbiome sequencing capabilities.
  • Stanford StartXminorStrategic or Co-development PartnerAccelerator program participant at Stanford University providing startup support, mentorship, and resources.
  • TechCrunch Disrupt BattlefieldminorStrategic or Co-development PartnerCompeted as TOP 6 (TOP 0.2%) finalist at TechCrunch Disrupt startup competition, gaining visibility and recognition in the startup ecosystem.
  • CPG and Therapeutic CompaniesminorStrategic or Co-development PartnerStrategic partnership opportunities for CPG and therapeutic companies including custom discovery programs, strain licensing, formulation support, clinical validation, and regulatory support using Parallel Health's quantitative microbiome analysis platform.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Parallel Health competitors and assessment

Company assessment

Direct peers

  • Curology: Telehealth dermatology provider offering personalized prescription skincare for acne and anti-aging via subscription. Closest direct competitor in the personalized tele-derm + custom Rx category Parallel operates in.
  • Apostrophe: Online dermatology practice delivering customized compounded prescription skincare. Directly comparable business model of telehealth consultation + custom compounded Rx delivered to consumer.
  • Atolla: Data-driven personalized skincare using at-home testing to formulate serums. Highly comparable on the test-driven, custom-formulation, DTC-subscription model.
  • Proven Skincare: AI-personalized skincare brand using a personalization quiz and custom-formulated products. Comparable on the AI-driven, custom formulation, DTC model aimed at anti-aging consumers.
  • Mother Dirt: Microbiome-focused skincare brand built around live bacterial topical products. Direct peer in the consumer microbiome skincare category, sharing Parallel's positioning.
  • Codex Beauty: Microbiome-focused clinical skincare brand with a BiaSkin platform combining prebiotics, probiotics and postbiotics. Comparable on microbiome + clinical claims positioning.

Broad incumbents

  • Hims & Hers Health: Large public telehealth platform that has expanded into dermatology and personalized skincare. Competes in tele-derm and custom Rx but as part of a much broader men's/women's health portfolio.

Emerging players

  • Sundial Skin: Early-stage microbiome skincare brand targeting acne and chronic skin conditions with proprietary topical strains. Emerging player in adjacent microbiome skincare niche.
  • DermaDNA: Genetic and microbiome-based personalized skincare offering tailored regimens from DNA and skin analysis. Emerging player in the personalized skincare diagnostics category.
  • SkinDNA: Genetic-based skincare analysis and product recommendation platform. Adjacent personalized skincare diagnostics peer leveraging biological data for custom regimen recommendations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Parallel Health social profiles

Digital presence

Parallel Health compliance and trust

Trust signal

Compliance2 records

Parallel Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Parallel Health leadership team

Management profile

Number of profiles

Profiles3 records

Parallel Health funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Parallel Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parallel Health

What does Parallel Health do?

Parallel Health sells the MD-03 Protocol™, a precision skin health system that combines at-home quantitative whole genome sequencing skin microbiome testing, 1:1 telehealth consultations with board-certified dermatologists, and custom-compiled active phage serums personalized to each customer's Skin Microbiome Type™. The company also sells individual precision skincare products (Blue Biotic™ Peptide Cream, Holy Calming Cleanser, Skin Barrier Biotic™ Cream), stand-alone microbiome test kits, custom compounded prescriptions, and condition-specific protocols for acne, eczema, rosacea, body odor, hidradenitis suppurativa, and scalp issues, available via subscription or à la carte purchase.

Is Parallel Health a public or private company?

Parallel Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Parallel Health founded?

Parallel Health was founded in 2020. It employs 11 to 50 people.

Where is Parallel Health based?

Parallel Health is headquartered in San Francisco, United States, in the North America region.

How does Parallel Health make money?

Four revenue lines are on record. MD-03 Protocol Subscription is the primary driver. The others are skincare Product Sales, clinical Research Services and microbiome Test Kits.

Who are Parallel Health's main competitors?

Direct peers on record are Curology, Apostrophe, Atolla, Proven Skincare, Mother Dirt and Codex Beauty. Hims & Hers Health is listed as a broad incumbent. Emerging players are Sundial Skin, DermaDNA and SkinDNA.

Does Parallel Health have an API?

No public API is recorded for Parallel Health.

What industry is Parallel Health in?

Parallel Health's product category is Microbiome Dermatology / Precision Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 456120 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyParallel Health joins Blue Shield of California network to expand access to personalized skin careParallel Health has joined the Blue Shield of California provider network, making its microbiome-guided dermatology services available in-network to Blue Shield members in California. The company is now in-network with four of California's largest commercial insurers—Aetna, Cigna, UnitedHealthcare, and Blue Shield of California—covering more than 28 million lives across the state. The milestone expands access to Parallel Health's MD-03 Protocol, which combines whole-genome microbiome sequencing, Metabolic Microbiome Profiling, custom phage cocktails, and clinician-prescribed compounded formulations delivered to patients.EIN PresswireParallel Health Joins Blue Shield of California, Expanding Access to Microbiome Dermatology™ in CaliforniaParallel Health joined Blue Shield of California, becoming in-network with Aetna, Cigna, UnitedHealthcare, and Blue Shield of California, covering over 28 million Californians. The move expands access to its MD-03 Protocol, which uses microbiome sequencing and phage treatments for skin conditions like acne and psoriasis.EIN PresswireParallel Health Expands Multi-Carrier Network to UnitedHealthcare in CaliforniaParallel Health announced it has achieved in-network status with UnitedHealthcare in California, making it now in-network with three of the nation's largest commercial insurers: UnitedHealthcare, Cigna Healthcare, and Aetna. This milestone makes Parallel Health the only Microbiome Dermatology platform with multi-carrier insurance coverage in the United States, with UnitedHealthcare alone covering more than 49 million members nationally. The expansion removes a significant financial barrier, making microbiome-based dermatology accessible to millions of insured Californians for the first time through the company's telehealth platform and board-certified dermatologists.Longevity.TechnologyParallel Health’s skin microbiome tool aims at precision aging careParallel Health, a San Francisco-based precision skin health company, announced Metabolic Microbiome Profiling, a new technology that measures what skin microbiome is actively producing rather than just identifying which microbes are present, representing a shift from descriptive to functional microbiome analysis. The company plans to translate these metabolic profiling results into personalized care plans through its MD-03 Protocol delivered via telehealth under board-certified dermatological oversight. If validated, this approach could enable more targeted and predictive dermatological treatments rather than the current trial-and-error model for skin aging interventions.EIN PresswireParallel Health Announces Technology to Map Skin Microbiome Metabolic Function, Advancing Precision Skin AgingParallel Health announced Metabolic Microbiome Profiling, a technology that maps specific bioactive compounds an individual's skin microbiome is actively synthesizing or failing to produce, including vitamins, antioxidants, short-chain fatty acids, peptides, and lipids that directly influence skin aging, barrier integrity, and immune function. The technology addresses a key gap in microbiome science where species identification alone cannot determine metabolic function, enabling personalized clinical interventions. The company translates these profiling results into personalized protocols delivered through its MD-03 Protocol via telehealth under dermatological oversight.EIN PresswireInc. Names Natalise Kalea Robinson of Parallel Health to Its 2026 Female Founders 500 ListInc. has named Natalise Kalea Robinson, CEO of Parallel Health, to its 2026 Female Founders 500 List, an annual honor recognizing the most innovative women entrepreneurs in the United States. The 2026 honorees collectively generated approximately $12.3 billion in 2025 revenue and $12.2 billion in funding to date, highlighting the economic impact of women-led businesses. Parallel Health is a vertically integrated precision health platform spanning telehealth, microbial genomic analysis, AI, and personalized compounded prescriptions, with eight patents pending and in-network status with Aetna and Cigna in California.EIN PresswireExpanding Access to Precision Skin Health: Parallel Health Goes In-Network With Cigna Healthcare in CaliforniaParallel Health, a precision skin health company specializing in microbiome dermatology, announced it has achieved in-network status with Cigna Healthcare in California, marking its second major national insurance carrier partnership. The agreement establishes Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the United States, following an earlier partnership with Aetna. The company plans to pursue additional in-network agreements with major insurers as part of its goal to make microbiome-informed dermatology an affordable, covered benefit for commercially insured Americans.ParallelhealthShould You Drink Your Skincare? Wellness Shots vs. TopicalsThe article evaluates the efficacy of oral skincare supplements, concluding that while collagen peptides clinically improve skin hydration and elasticity, other trends like biotin and carrot-based 'retinol' shots offer minimal or no proven benefits. It argues that topical treatments, particularly prescription actives like tretinoin, deliver superior and faster results by addressing multiple skin concerns directly without digestive breakdown. The piece specifically promotes Parallel Health's microbiome-based precision skincare as a more effective alternative to viral wellness drinks.GreyBTop 5 Microbiome Gut Health StartupsIn August 2025, the Microbiome Therapeutics Innovation Group (MTIG) petitioned the FDA to close the "IND loophole," a policy that had allowed doctors to use unapproved stool-based treatments like fecal transplants under relaxed safety rules after reports of serious infections and deaths, prompting the FDA to require all microbiome treatments to meet strict safety, effectiveness, and manufacturing standards. The article profiles five high-potential microbiome startups — Parallel Health, Ibiome Biology, MarvelBiome, Resbiotic Nutrition, and Synbiotic Health — all working on microbiome-based therapies targeting areas beyond gut health, including skin, brain, respiratory, and metabolic conditions, with combined funding ranging from $2.3 million to $13.8 million. The global human microbiome market is projected to grow from $1.6 billion in 2025 to $8.9 billion by 2034, driven by precision medicine platforms and major deals including PepsiCo's $1.95 billion acquisition of prebiotic soda brand Poppi.USA TODAYParallel Health: Personalizing Tele-Dermatology by Leveraging AIParallel Health, founded by Jason Phillips and Natalise Kalea Robinson, offers skin microbiome testing and phage therapy for chronic skin issues. The company provides telehealth dermatology, cutting wait times from six months to one month, and has launched in Japan. It is seeking dermatologists and longevity clinics for partnerships.